Evaluation of a novel genetic testing system for detection of macrolide resistance Mycoplasma pneumoniae

Evaluation of a novel genetic testing system for detection of macrolide resistance Mycoplasma pneumoniae - Evaluation of a novel genetic testing system for detection of macrolide resistance Mycoplasma pneumoniae

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036804

Enrollment

150

Registered

2019-05-20

Start date

2018-11-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma pneumoniae infection

Interventions

(1). Perform a test with the Mycoplasma pneumoniae antigen rapid test kit. (2).Conduct the test using this research test reagent and equipment. Nucleic acid extraction is performed using the residual

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients aged 1 and over at the time of consent acquisition. (2) Patients suspected of Mycoplasma pnuemoniae infection due to fever, cough, imaging test, etc. (3) Patients considered necessary to carry out Mycoplasmdiagnostic testing/ (4) After receiving sufficient explanation for participation in this research, with sufficient understanding, patients who have obtained consent from the researcher.

Exclusion criteria

Exclusion criteria: (1) Patients who could not collect enough samples for evaluation. (2) Patients who the research director judged inappropriate as a research subject.

Design outcomes

Primary

Measure	Time frame
Detection performance of Mycoplasma pneumoniae gene	—

Countries

Japan

Contacts

Public ContactToshihiko Kakiuchi

Faculty of Medicine, Saga University Department of Pediatrics

kakiucht@cc.saga-u.ac.jp0952-34-2314

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026